Trials / Completed
CompletedNCT04224246
Impact of Gamma-OH on Sleep in ICU Patients
Impact of Gamma-OH on Sleep in ICU Patients Difficult to Wean from Mechanical Ventilation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Main objective of the trial is to assess sleep quality with Gamma-OH® in patients difficult to wean from mechanical ventilation in the ICU.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gamma Hydroxybutyrate | Gamma-OH® will be administered intravenously at a dose of 20 mg/kg/h for 6 hours |
Timeline
- Start date
- 2020-02-27
- Primary completion
- 2023-02-09
- Completion
- 2023-02-09
- First posted
- 2020-01-13
- Last updated
- 2025-02-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04224246. Inclusion in this directory is not an endorsement.